Gritstone bio, Inc. (GRTS) Financials
GRTS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 177.8 million | 125.9 million |
2023-09-30 | 187.2 million | 113.2 million |
2023-06-30 | 222.6 million | 113.1 million |
2023-03-31 | 210.0 million | 69.1 million |
GRTS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -34.6 million | 2.8 million |
2023-09-30 | -32.2 million | 3.0 million |
2023-06-30 | -32.7 million | 2.9 million |
2023-03-31 | -41.7 million | 2.9 million |
GRTS Net Income
No data available :(
GRTS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 81.6 million | - | 64.6 million |
2023-09-30 | 83.9 million | - | 65.4 million |
2023-06-30 | 114.5 million | 29.7 million | 65.7 million |
2023-03-31 | 145.8 million | 29.6 million | 19.2 million |
GRTS Shares Outstanding
GRTS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 191000 | 32.9 million | 7.9 million | 1.9 million |
2023-09-30 | 1.1 million | 32.8 million | 7.4 million | - |
2023-06-30 | 1.7 million | 31.0 million | 6.7 million | - |
2023-03-31 | 1.6 million | 30.5 million | 6.7 million | - |
GRTS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 29000 | 1.9 million |
2023-09-30 | 1.6 million | 2.0 million |
2023-06-30 | 400000 | 1.6 million |
2023-03-31 | 542000 | 30.5 million |
GRTS
Price: $0.96
52 week price:
Earnings Per Share: -1.20 USD
P/E Ratio: -1.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 427892
Market Capitalization: 95.1 million